Myconail (Ciclopirox)

ciclopirox, the active ingredient in Myconail, is an antifungal presented as an unknown/unknown for cutaneous use. It treats superficial fungal infections such as athlete’s foot, ringworm, jock itch, nail fungus and seborrheic dermatitis in adults and children.

GNH USA supplies Myconail as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows European Union quality standards and offers reliable global logistics for timely delivery. Its network ensures compliance with import regulations and supports customers with technical and regulatory assistance.

Myconail, containing ciclopirox, is used to treat fungal skin and nail conditions by inhibiting fungal growth.

Tinea pedis: Reduces itching, scaling and redness associated with athlete’s foot. Tinea corporis: Clears ring‑shaped lesions and alleviates inflammation. Tinea cruris: Improves jock itch symptoms and promotes skin healing. Onychomycosis: Helps eradicate fungal infection of the toenails and improves nail appearance. Seborrheic dermatitis: Controls flaking and erythema on scalp and facial areas.

Topical ciclopirox may cause local skin reactions, most of which are mild and reversible.

Common Side Effects: - Mild burning sensation at the application site. - Transient itching or pruritus. - Localized redness or erythema. - Dryness or peeling of the skin.

Serious or Rare Side Effects: - Severe contact dermatitis with swelling and blistering. - Allergic reaction presenting as urticaria or angioedema. - Extensive skin irritation requiring discontinuation. - Systemic hypersensitivity signs such as fever or malaise.

Before using Myconail, consider the following precautions to ensure safe and effective treatment.

Pregnancy: Consult a healthcare professional before application. Breastfeeding: Discuss potential risks with a physician. Skin integrity: Avoid use on broken, inflamed or ulcerated skin. Concurrent antifungal therapy: Evaluate need to prevent overlapping toxicity. Allergy: Discontinue immediately if hypersensitivity signs appear. Store at ambient temperature: Keep in original container, protect from moisture and light.

Ciclopirox may interact with other topical or systemic agents; awareness of these interactions helps minimize adverse outcomes.

Major Interactions (Avoid): - Systemic antifungal medications: concurrent use may increase risk of toxicity. - Topical corticosteroids: may reduce ciclopirox efficacy. - Chemotherapeutic agents: potential additive toxicity on skin.

Moderate Interactions (Monitor Closely): - Alcohol‑based skin products: can enhance local irritation. - Other topical agents (e.g., retinoids): monitor for increased skin sensitivity. - Phototherapy: observe for exaggerated skin reactions.